STSara Tabtabai

Sara Tabtabai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sara Tabtabai has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Thirty‐Day All‐Cause Readmissions After Pregnancy‐Associated Hospitalizations With Heart Failure in the United States: Analysis of the Nationwide Readmissions Database

    by Emma Barry, Min Jung Kim, Sarah Goldstein, Anna Denoble, Christine Hsueh, Patricia Chavez, Sara Tabtabai

    Background: Cardiovascular disease is the leading cause of pregnancy‐related morbidity and mortality in the United States. There is a paucity of data regarding pregnancy‐associated heart failure readmissions. This study aims to characterize the 30‐day heart failure readmission patterns in pregnancy‐associated admissions. Methods: The National Readmission Database from 2016 to 2021 was used to identify women aged 13 to 49 with an index hospitalization with heart failure as the primary or secondary diagnosis during a pregnancy‐related admission, identified by diagnosis‐related group codes and International Classification of Diseases, Tenth Revision ( ICD‐10 ) codes. The primary outcome was 30‐day all‐cause readmission. Survey‐weighted descriptive analyses and hierarchical multivariable logistic regression were used to characterize readmission patterns and identify independently associated factors. Results: Among 19 452 eligible index hospitalizations, 2659 were followed by a 30‐day readmission; the survey‐weighted readmission rate was 13.5%. In the fully adjusted model, Medicare and Medicaid coverage, residence in a small metropolitan area, greater All Patient Refined Diagnosis‐Related Group severity, discharge with home health care, and discharge against medical advice were associated with higher odds of readmission. Deficiency anemia, chronic pulmonary disease, diabetes without chronic complications, renal failure, solid tumor without metastasis, and cardiovascular or respiratory disorders complicating pregnancy were also independently associated with increased readmission. Conclusions: Approximately 1 in 7 pregnancy‐associated hospitalizations complicated by heart failure was followed by a 30‐day all‐cause readmission. Readmission risk reflected a combination of illness severity, discharge disposition, payer status, geographic location, and selected medical and pregnancy‐related comorbidities. These findings support the development and evaluation of individualized, multidisciplinary transitional‐care strategies for patients at highest risk.

  • Open Access

    Association between Semaglutide 2.4 mg and Risk of Cardiovascular Events in Patients with Heart Failure in the Real-world: Results from the SCORE-HF Study

    by Kim G. Smolderen, Carlos Mena-Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Prashanth Iyer, Filip K. Knop, Michael G. Nanna, et al.

  • Open Access

    Pregnancy-related Heart Failure Readmissions in the US: Analysis of the Nationwide Readmissions Database

    by Emma Barry, Min Jung Kim, Sarah A Goldstein, Anna E. Denoble, Patricia Chavez, Christine Hsueh, Sara Tabtabai

    Background: Cardiovascular disease (CVD) is the leading cause of pregnancy-related morbidity and mortality in the United States. Several studies have evaluated readmission rates in the general HF population, but in patients with pregnancy-related HF, readmissions have been understudied. This study aims to characterize the 30-day HF readmission patterns in pregnancy-related admissions to identify vulnerable patient populations. Methods: The National Readmission Database from 2016 to 2021 was used to identify women aged 13-49 with an index hospitalization in which HF was coded as either the primary or secondary diagnosis during a pregnancy-related antepartum, delivery, or postpartum admission, identified by diagnosis-related group (DRG) codes and ICD-10 codes. The primary outcome was 30-day all-cause readmission. We performed descriptive and comparative analyses to describe the differences in patient characteristics and readmission patterns between groups. Results: The overall 30-day all-cause readmission rate was 13% when readmissions for delivery were excluded. The readmission rate increased with age, peaking at 15.1% in the 38-49yr age group. Higher readmission rates were also associated with combined (systolic and diastolic) HF (16.1%), systolic HF (14.8%), lower socioeconomic status (15.3%), substance use disorder (17.2%), and alcohol use (18.6%). Patients whose index hospitalization was for delivery had the highest absolute risk of 30-day readmission at 19.3%. Readmissions peaked between days 6 and 8 post discharge, with more than 50% of all readmissions occurring within the first two weeks post-discharge Conclusions: In our study, the highest risk of readmission occurred after an index hospitalization for delivery, and most readmissions occurred in the first 2 weeks post-discharge. Our findings suggest that a post-discharge follow up within 7 days of admission complicated by HF should be extended to patients with pregnancy-related HF and effective readmission reduction strategies must include a better understanding of heart failure phenotypes, and a proactive approach to addressing social risk factors.

  • Open Access

    The Effect of a Best Practice Advisory on the Utilization and Impact of Palliative Care Consultation in Heart Failure Hospitalizations

    by Kaitlyn S. Gooding, Vamsidhar V. Naraparaju, Beth Esstman, Dorothy B. Wakefield, Megan Evjen, Ahmed Naseer, Sara Tabtabai

    Background: Few studies examine palliative care consultations (PCC) in acute decompensated heart failure (ADHF) admissions. Prior data suggest that 6% of admitted patients are referred for PCC. This study evaluates the effect of a best practice alert (BPA) embedded in the electronic record on PCC utilization and outcomes. Methods: Patients admitted between May 1, 2020, and June 30, 2022, with ADHF were included. BPA was triggered at admission for patients with ≥3 ADHF admissions in 6 months or PCC during prior admission. Subjects were divided into early PCC (less than three days of admission), late PCC (more than three days), and no PCC. Demographics, BPA utilization, length of stay (LOS), and cost were compared between groups. Results: Of 684 patients, 18% received PCC: 13.1% had early PCC, 5.12% late PCC, and 81.6% no PCC. Early PCC patients were older with more comorbidities. Patients receiving PCC had lower ejection fraction ( p = 0.04). Median LOS was longest in the late PCC group (12 days, p ≤ 0.01) and similar in early and no PCC groups (six and five days, respectively) and remained significant in multivariate analysis. White patients were more likely to receive PCC compared with Black and other races. The late PCC group had the lowest readmission rate at 5.7%; 28 of the 35 patients changed their goals of care to hospice, “do not re-hospitalize,” or “do not intubate/do not resuscitate.” Conclusions: PCC may influence therapy for patients with ADHF and reduce the readmission rate. Clinician biases remain despite the utilization of BPA, with a modest effect on PCC utilization.